Skip navigation

Peptinnovate Ltd


Telephone: 01438 906978

Peptinnovate is a clinical stage biopharmaceutical company discovering and developing new treatments for inflammatory disease. Peptinnovate is founded on the principle that mycobacterium tuberclosis (mTB) can modify the human immune system through co-evolution with man. mTB, over 40,000 years, developed mechanisms in which the allergic and asthma phenotypes in man can be reduced. Peptinnovate has identified molecules dervied from mTB that appear to have the same desired immuno-modulating effects in preclinical models and has optimised proprietary drug candidates. Backed by an expert team, Peptinnovate is focused on developing a range of therapies for debilitating respiratory and immuno-inflammatory diseases.